trem2 apc (R&D Systems)
Structured Review

Trem2 Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 66 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trem2+apc/Human%2FMouse+TREM2+APC-conjugated+Antibody/bio_rxiv__64898__2026__01__22__701073-257-34-37
Average 95 stars, based on 66 article reviews
Images
1) Product Images from "YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer"
Article Title: YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Journal: bioRxiv
doi: 10.64898/2026.01.22.701073
Figure Legend Snippet: A) GSEA analysis of MoMacVERSE monocyte/macrophage signatures using RNA-sequencing data from . B) GSEA enrichment plots of two independent TREM2 + macrophage signatures , . C) GSEA of Hallmark genes. D) Flow cytometry analysis of TREM2 surface expression in monocyte-derived macrophages exposed to HCC827 CM. E) Immunohistochemical staining of TREM2 from syngeneic Del19.2 model in vivo experiment depicted in . F) Quantification of TREM2 + area from samples in (E) using QuPath. G) TREM2 gene expression in EGFR TKI-treated patients. RNA-sequencing data from Gurule et al. . H) Correlation of macrophage and T cell abundance from CIBERSORTx analysis of RNA sequencing data in (G). CM = conditioned medium. Paired (D) or unpaired (F) t-tests were used to assess statistical significance. **, P-value <0.01; *, P-value < 0.05.
Techniques Used: RNA Sequencing, Flow Cytometry, Expressing, Derivative Assay, Immunohistochemical staining, Staining, In Vivo, Gene Expression
Figure Legend Snippet: A) Experimental set-up for conditioned media collection and YAP/TEAD inhibition in DTP cells. B) RNA-sequencing analysis of the expression of genes encoding for secreted proteins in HCC827 and HCC4006 cell lines treated as in (A). C) YAP-driven secretome in HCC827 and HCC4006 cells, determined by genes upregulated in DTPs, and downregulated upon TEAD inhibition. D) Shared YAP-driven secretome in HCC827 and HCC4006. E) ChIP-seq analysis of YAP binding of shared secretome genes. F) List of shared YAP-driven secretome from (D), with genes previously associated with macrophage activation, migration, or polarization highlighted in bold. G) CD163 expression of THP-1 cells treated with HCC827 conditioned media collected as in (A) using 500 nM ORM-47286 or 10 mM MYF-01-37 for TEAD inhibition. H) Flow cytometry analysis of CD163 and TREM2 cell surface expression in human peripheral blood monocytes exposed to HCC827 conditioned media. Data in (G) presented as mean ± SD. Unpaired (G) and paired (H) one-way ANOVA was used to assess statistical significance. **, P-value <0.01; *, P-value < 0.05.
Techniques Used: Inhibition, RNA Sequencing, Expressing, ChIP-sequencing, Binding Assay, Activation Assay, Migration, Flow Cytometry
Related Articles
Staining:Article Title: Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation. Article Snippet: For detection of microglial surface markers, iMGLs were incubated for 10 min on ice with antiCD16/CD32 to block Fc receptors (1:50; Miltenyi Biotec, Cat #:120-000-442) and with Zombie AquaTM to identify live cells. .. Then, iMGLs were stained with CD11b-PeCy7 (Cat#: 101216; Clone: M1/70), CD45-Alexa 700 (Cat#: 304024; Clone: H130), CD80-BV421 (Cat#: 305222, Clone: 2D10), CD86-PerCP/Cy5.5 (Cat#: 30420, Clone: IT2.2), MERTK (Cat#: 367620, clone: 590H11G1E3) all from BioLegend, CD14-PeCy7 (Invitrogen, Cat#: 25-0149-41, Clone: 61D3), HLA-DR-PECF594 (BD, Cat#: 562331 clone: G46-6), Article Title: YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer Article Snippet: Cell viability was assessed with Fixable Viability Dye eFluorTM 450 (Invitrogen, eBioscienceTM, 1:1000), and Human BD Fc BlockTM (clone Fc1, BD PharmingenTM, cat# 564219, 1:50) was used to diminish nonspecific antibody binding. .. Surface staining for markers was carried out in PBS + 2 % FBS with the following antibodies (1:100 dilution): CD64-PE (clone 10.2, BD PharmingenTM), CD206-AF488 (clone 15-4, BioLegend), CD163-BV711 (clone GHI_61, BD HorizonTM), and Article Title: A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer's disease. Article Snippet: .. For phagocytosis assessment, cells were incubated with commercially available fluorescein isothiocyanate-conjugated monomeric Aβ (Bachem, Cat 4033502; a 1:5 dilution was prepared in 200 μl of RPMI1640 media supplemented with 10% fetal bovine serum, using a 10 ug/ml stock solution in DMSO) and yellow-green microspheres (Polysciences) for 30 min at 37 °C in a CO2 incubator followed by surface staining anti-CD45-eF450 (clone: HI30, Thermo Fisher Scientific 48-0459-42), anti-CD11b-BV605 (clone: M1/70, BioLegend 101257), Article Title: Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia Article Snippet: The cells were washed and stained with 2 μM BODIPY 493/503 (ThermoFisher D3922) for 15 minutes at 37°C. .. After washing, the cells were stained with CD3-BV605 [clone UCHT1] (BioLegend Cat# 300459, RRID: AB_2564379), CD19-BV605 [clone HIB19] (BioLegend Cat# 302243, RRID: AB_2562014), CD56-BV605 [clone 5.1H11] (BioLegend Cat# 362537, RRID: AB_2565855), CD45-PE/Cy7 [clone HI30] (BioLegend Cat# 304016, RRID: AB_314404), HLADR-AF700 [clone L243] (BioLegend Cat# 307626, RRID: AB_493771), CD1c-BV650 [clone L161] (BioLegend Cat# 331541, RRID: AB_2800865), CD74-PE [clone LN2] (BioLegend Cat# 326807, RRID: AB_2229059) antibodies (Biolegend), and Article Title: A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease Article Snippet: .. For phagocytosis assessment, cells were incubated with commercially available fluorescein isothiocyanate-conjugated monomeric Aβ (Bachem, Cat 4033502; a 1:5 dilution was prepared in 200 μl of RPMI1640 media supplemented with 10% fetal bovine serum, using a 10 ug/ml stock solution in DMSO) and yellow-green microspheres (Polysciences) for 30 min at 37 °C in a CO 2 incubator followed by surface staining anti-CD45-eF450 (clone: HI30, Thermo Fisher Scientific 48-0459-42), anti-CD11b-BV605 (clone: M1/70, BioLegend 101257), Incubation:Article Title: A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer's disease. Article Snippet: .. For phagocytosis assessment, cells were incubated with commercially available fluorescein isothiocyanate-conjugated monomeric Aβ (Bachem, Cat 4033502; a 1:5 dilution was prepared in 200 μl of RPMI1640 media supplemented with 10% fetal bovine serum, using a 10 ug/ml stock solution in DMSO) and yellow-green microspheres (Polysciences) for 30 min at 37 °C in a CO2 incubator followed by surface staining anti-CD45-eF450 (clone: HI30, Thermo Fisher Scientific 48-0459-42), anti-CD11b-BV605 (clone: M1/70, BioLegend 101257), Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice Article Snippet: .. For flow cytometry experiment in , after a 15 min incubation with Fc block at 4°C, the following antibodies were added in a 10 μl master mix: CD11b-PerCP/Cy5.5 (M1/70, 561114, 1:400, BD Biosciences), CD45-APC/Cy7 (30F11, 103116, 1:400, BioLegend), MitoTracker Green (M7514, 100nM, Invitrogen), Galectin-3-PE (M3/38, 12–5301-82, 1:250, Invitrogen), Article Title: A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease Article Snippet: .. For phagocytosis assessment, cells were incubated with commercially available fluorescein isothiocyanate-conjugated monomeric Aβ (Bachem, Cat 4033502; a 1:5 dilution was prepared in 200 μl of RPMI1640 media supplemented with 10% fetal bovine serum, using a 10 ug/ml stock solution in DMSO) and yellow-green microspheres (Polysciences) for 30 min at 37 °C in a CO 2 incubator followed by surface staining anti-CD45-eF450 (clone: HI30, Thermo Fisher Scientific 48-0459-42), anti-CD11b-BV605 (clone: M1/70, BioLegend 101257), Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice. Article Snippet: .. For flow cytometry experiment in Figure 5, after a 15 min incubation with Fc block at 4 C, the following antibodies were added in a 10 ml master mix: CD11b- PerCP/Cy5.5 (M1/70, 561114, 1:400, BD Biosciences), CD45-APC/Cy7 (30F11, 103116, 1:400, BioLegend), MitoTracker Green (M7514, 100nM, Invitrogen), Galectin-3-PE (M3/38, 12-5301-82, 1:250, Invitrogen), Flow Cytometry:Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice Article Snippet: .. For flow cytometry experiment in , after a 15 min incubation with Fc block at 4°C, the following antibodies were added in a 10 μl master mix: CD11b-PerCP/Cy5.5 (M1/70, 561114, 1:400, BD Biosciences), CD45-APC/Cy7 (30F11, 103116, 1:400, BioLegend), MitoTracker Green (M7514, 100nM, Invitrogen), Galectin-3-PE (M3/38, 12–5301-82, 1:250, Invitrogen), Article Title: Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia Article Snippet: The cells were washed and stained with 2 μM BODIPY 493/503 (ThermoFisher D3922) for 15 minutes at 37°C. .. After washing, the cells were stained with CD3-BV605 [clone UCHT1] (BioLegend Cat# 300459, RRID: AB_2564379), CD19-BV605 [clone HIB19] (BioLegend Cat# 302243, RRID: AB_2562014), CD56-BV605 [clone 5.1H11] (BioLegend Cat# 362537, RRID: AB_2565855), CD45-PE/Cy7 [clone HI30] (BioLegend Cat# 304016, RRID: AB_314404), HLADR-AF700 [clone L243] (BioLegend Cat# 307626, RRID: AB_493771), CD1c-BV650 [clone L161] (BioLegend Cat# 331541, RRID: AB_2800865), CD74-PE [clone LN2] (BioLegend Cat# 326807, RRID: AB_2229059) antibodies (Biolegend), and Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice. Article Snippet: .. For flow cytometry experiment in Figure 5, after a 15 min incubation with Fc block at 4 C, the following antibodies were added in a 10 ml master mix: CD11b- PerCP/Cy5.5 (M1/70, 561114, 1:400, BD Biosciences), CD45-APC/Cy7 (30F11, 103116, 1:400, BioLegend), MitoTracker Green (M7514, 100nM, Invitrogen), Galectin-3-PE (M3/38, 12-5301-82, 1:250, Invitrogen), Blocking Assay:Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice Article Snippet: .. For flow cytometry experiment in , after a 15 min incubation with Fc block at 4°C, the following antibodies were added in a 10 μl master mix: CD11b-PerCP/Cy5.5 (M1/70, 561114, 1:400, BD Biosciences), CD45-APC/Cy7 (30F11, 103116, 1:400, BioLegend), MitoTracker Green (M7514, 100nM, Invitrogen), Galectin-3-PE (M3/38, 12–5301-82, 1:250, Invitrogen), Article Title: The microglial response to inhibition of Colony-stimulating-factor-1 receptor by PLX3397 differs by sex in adult mice. Article Snippet: .. For flow cytometry experiment in Figure 5, after a 15 min incubation with Fc block at 4 C, the following antibodies were added in a 10 ml master mix: CD11b- PerCP/Cy5.5 (M1/70, 561114, 1:400, BD Biosciences), CD45-APC/Cy7 (30F11, 103116, 1:400, BioLegend), MitoTracker Green (M7514, 100nM, Invitrogen), Galectin-3-PE (M3/38, 12-5301-82, 1:250, Invitrogen), |

![Representative plots illustrate the sequential gating of SVF cells, including singlet and CD45 populations, macrophages (CD11bF4/80), and downstream subsets (CD11c, CD206, CD9, <t>TREM2).</t> Gates are indicated to show the strategy used for analysis and sorting. This figure is intended as a schematic overview of the gating hierarchy; detailed quantitative data and subset percentages are reported in Wu et al. [16].](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0519/pmc12550519/pmc12550519__BioProtoc-15-20-5479-g004.jpg)